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0 [-5, 5] vs. no LBBB: 0 [0, 10], p¼0.003).
CONCLUSIONS New LBBB is not uncommon after TAVR with higher
incidence observed in patients receiving self-expanding Medtronic
CoreValve system. Although a small proportion of patients progressed
to CHB, the majority did not require PPM implantation. New LBBB was
associated with worse left ventricular EF on 30-day follow-up.
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BACKGROUND As transcatheter aortic valve replacement (TAVR) is
being considered for surgical patients of lower risk and younger age,
concerns remain regarding TAVR durability. From a valve design
perspective, durability decreases with increased stresses on the stent
and leaﬂets. Patient annulus sizes can fall within the grey zone be-
tween two TAVR sizes, but the impact of valve size on TAVR stresses
is unknown. The goal of this study was to determine and compare
stent and leaﬂet stresses of 2 TAVR sizes using exact fully expanded
geometry.
METHODS Edwards Sapien XT 26mm and 29mm (Edwards Life-
sciences, Inc) underwent micro-computed tomography scanning.
Radiologic images were used to create precise models including stent,
leaﬂets, Dacron, and suture connections. Finite element meshes were
generated and simulations were performed using ABAQUS software to
load both TAVR sizes to 80mmHg then 120mmHg. Analyses of 26 and
29mm Sapien XT were compared to determine differences in stent and
leaﬂet stresses at 120mmHg.
RESULTS For TAVR stents, peak ﬁrst principal stresses on 26mm and
29mm Sapien XT were 68.1MPa and 62.0MPa, respectively (Figure 1);
while peak second principal stresses were -67.7MPa and -61.2MPa,
respectively. For TAVR leaﬂets, peak ﬁrst principal stresses were
5.9MPa and 5.1MPa for 26mm and 29mm Sapien XT, respectively;
while peak second principal stresses were -5.05MPa and -3.8MPa,
respectively.CONCLUSIONS Finite element analyses demonstrated that for both
stents and leaﬂets, stresses were greater in the 26mm compared to
29mm Edwards Sapien XT. Our results suggest the smaller TAVR size
had increased stresses which may impact durability. Comparison with
similarly sized surgical bioprostheses may lead to further insight into
relative TAVR durability.
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BACKGROUND Evaluation for transcatheter aortic valve replacement
(TAVR) has brought a renewed interest in the role for balloon aortic
valvuloplasty (BAV) in the management of patients with severe aortic
stenosis (AS). The current study is the ﬁrst prospective study of BAV
analyzed by intent-to-treat.
METHODS This is a prospective, two center study of 100 high-risk
patients undergoing BAV for management of severe AS. Before the
procedure, physicians assigned intent of BAV as 1) bridge to decision
for treatment (BTD); 2) therapeutic bridge to planned therapy (BTX);
or 3) palliation (PAL). Patients in the BTD arm underwent clinical
assessment at 30 days in the valve clinic to determine eligibility for
deﬁnitive valve therapy. Baseline demographics were recorded as per
the Society of Thoracic Surgeons (STS) deﬁnitions. All patients were
followed to 1 year, with outcomes measured including procedural
complications, 30-day and 1-year mortality, and deﬁnitive valve
therapy.
RESULTS At baseline, the patients had a mean (standard deviation)
age of 80.6 (9.6) years, STS predicted risk of mortality of
11.4%(7.1%), and there were 91 (91.0%) patients with a Class III or IV
New York Heart Association Congestive Heart Failure. Intent and
treatment outcomes in the 100 patients enrolled are shown in the
ﬁgure: 73 BTD; 23 BTX; and 4 PAL. 30-day mortality for all patients
was 6/100 (6.0%). One of these patients was in the palliative cohort
and 5 were in the BTD cohort and were not referred for deﬁnitive
valve replacement. Other complications included cerebrovascular
accident in 2/100 (2.0%) and acute renal injury in 4/100 (4.0%). 1-year
mortality for patients who received deﬁnitive valve therapy was 6/54
(11.1%), with no valve was 32/42 (76.2%), and 3/4 (75.0%) for pallia-
tion. Of the patients in the BTD arm referred for deﬁnitive valve
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BTX arm referred for deﬁnitive valve therapy, the 1-year mortality was
1/16 (6.3%).
CONCLUSIONS BAV is used in high-risk patients with AS primarily in
a “bridging” role. As a decision tool, BAV appears to have a role in
properly selecting patients to undergo deﬁnitive valve therapy, with a
1-year survival in our study of patients in the BTD and BTX cohorts
who underwent valve replacement of 88.9%. BAV has a limited role in
palliation in terms of survivorship.
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BACKGROUND Accurate three-dimensional sizing of the aortic
annulus, aorta, and iliac arteries, commonly by computed tomography
angiography (CTA), is necessary for transcatheter aortic valve
replacement (TAVR). Iodinated contrast can result in contrast-
induced nephropathy in this patient population. Techniques for
reducing the contrast load may be beneﬁcial in these patients.
METHODS We performed CTA of the chest, abdomen, and pelvis on
12 patients being evaluated for possible TAVR using an indwelling
side-hole catheter (PAC) inserted from the right internal jugular
vein into the main pulmonary artery (PA). Power injection during
CTA was performed with 30-40mL of Omnipaque 350 (GE Health-
care) mixed with saline (50/50 mix) based on BMI. 12 control pa-
tients who underwent pre-TAVR CTA using standard contrast
volume (100-130mL) administered via peripheral IV were selected
for comparison during the same time period. All patients under-
went 256-slice aorto-iliac CTA (Brilliance- iCT, Philips) with retro-
spective gating. PAC group was scanned at 100 kVp if BMI >30, and
at 80 kVp if BMI <30. The control group had gated-helical CTA of
thorax at 100 kVp and helical CTA of abdomen at 120 kVp. Image
quality was assessed with a 4-point Likert scale (1-nondiagnostic; 4-
ideal) by 2 board-certiﬁed radiologists. Clinical and demographic
features of the two groups including height, weight, body surface
area (BSA), glomerular ﬁltration rate (GFR), and amount of contrast
used were obtained by retrospective chart review. Statistical ana-
lyses were used to determine signiﬁcant differences between the
two groups.
RESULTS Average age of the patients in the PAC and control groups
was 82.3 and 81.3 years, respectively (p¼0.7). Other demographic and
clinical features of the PAC and control groups included: weight of 151
vs. 170 lbs; body surface area of 1.77 vs. 1.86 m2 (p¼0.4); pre-CTA
GFR <60mL/min/1.73m2 in 72.7% vs. 16.7% of patients; and post-CTA
GFR<60mL/min/1.73m2 in 72.7% vs. 41.7% of the PAC and control
groups, respectively. The mean contrast used was 38.75 mL in the PACgroup vs. 103.3 mL in the control group (p<0.001). All scans were
graded as diagnostic and the median subjective score for both groups
via the Likert scale was 4 (ideal). Selected images are presented.
CONCLUSIONS Complete CTA imaging for TAVR evaluation with an
indwelling PA catheter signiﬁcantly reduced contrast loads by 63%,
while providing excellent vascular enhancement. Further reductions
in contrast load are possible with optimization of this novel technique.
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BACKGROUND Pulmonary hypertension (PH) may arise from both
pre-capillary and post-capillary etiologies which can be evaluated and
quantiﬁed by invasive hemodynamics (CATH). The impact of PH eti-
ology on all-cause mortality of patients with severe aortic stenosis
(AS) is unknown. Our hypothesis was that CATH classiﬁcation of PH
etiology allows for identiﬁcation of severe AS patients with combined
pre and post-capillary PH that would have the highest mortality risk.
METHODS Retrospective data collection of patients with severe AS
(AV area index  0.6 cm2/m2) and CATH with invasive hemodynamics
was performed. Patients were classiﬁed as having: a) no PH
(PAmean<25mmHg), b) pre-capillary PH (PAH, PAmean25mmHg and
pulmonary capillary wedge pressure, PCWP<15mmHg), c) post-capil-
lary passive PH (PAmean25mmHg, PCWP15mmHg and trans-
pulmonary gradient, TPG15 mmHg), and d) combined pre-post
capillary PH (PAmean25mmHg, PCWP15mmHg and
TPG>15mmHg). Multivariate Cox-proportional hazard model was
used for risk-adjustment comparisons.
RESULTS A total of 187 patients were identiﬁed with mean age of 77 
10 years, 62% male and 38% diabetic. After a median follow-up of 18
months (IQR: 5-27 months), there were 66 deaths (35%). According to
the etiology, 54 patients (29%) had no PH, 18 (10%) had PAH, 78 (42%)
had passive PH, and 37 (20%) had combined PH. After adjustments for
AVR (HR¼0.14, 95% CI 0.05-0.35,p<0.01), age, gender, BMI, diabetes,
and NYHA class, presence of combined PH by CATH was indepen-
dently associated with increased risk (HR vs. no PH¼2.49, 95% CI 1.09-
5.73, P¼0.03). (Figure 1)
CONCLUSIONS Post-capillary PH is very common in severe AS (62%).
Ascertainment of PH etiology by CATH is important as combined pre-
post capillary PH is associated with increased short-term mortality
despite adjustments for AVR and other comorbidities. Whether this
risk can be decreased by further interventions needs to be investi-
gated in future studies.
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